The licensing gamble: raising the stakes

  title={The licensing gamble: raising the stakes},
  author={James Featherstone and Si{\^a}n Renfrey},
  journal={Nature Reviews Drug Discovery},
Licensing activity for the top 20 pharmaceutical companies steadily increased during the decade 1988–1998, but has since slowed due to a change in licensing strategies. The increasing cost of securing access to late-stage development candidates has meant that companies are shifting their focus to earlier-stage opportunities. Furthermore, companies are… CONTINUE READING